An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic Syndromes
Clinical trial NCT01381809 · COMPLETED
Trial details
- NCT number
- NCT01381809
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2015-01-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.